Alyeska Investment Group, L.P. Johnson & Johnson Transaction History
Alyeska Investment Group, L.P.
- $25.4 Billion
- Q2 2025
A detailed history of Alyeska Investment Group, L.P. transactions in Johnson & Johnson stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 542,541 shares of JNJ stock, worth $105 Million. This represents 0.33% of its overall portfolio holdings.
Number of Shares
542,541
Previous 133,727
305.71%
Holding current value
$105 Million
Previous $22.2 Million
273.69%
% of portfolio
0.33%
Previous 0.09%
Shares
13 transactions
Others Institutions Holding JNJ
# of Institutions
4,768Shares Held
1.76BCall Options Held
18MPut Options Held
14.7M-
Vanguard Group Inc Valley Forge, PA237MShares$45.9 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY198MShares$38.4 Billion0.67% of portfolio
-
State Street Corp Boston, MA133MShares$25.7 Billion0.78% of portfolio
-
Jpmorgan Chase & CO New York, NY58.6MShares$11.4 Billion0.72% of portfolio
-
Geode Capital Management, LLC Boston, MA56.2MShares$10.9 Billion0.69% of portfolio
About JOHNSON & JOHNSON
- Ticker JNJ
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,614,479,872
- Market Cap $507B
- Description
- Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...